Vaccine News and Research

Latest Vaccine News and Research

Pre-existing SARS-CoV-2 antibodies may increase the breadth of mRNA vaccines, study suggests

Nearly three years into the pandemic, many of us now carry antibodies against the virus - due to an infection or two, a few doses of mRNA vaccine, or a round of monoclonal-antibody treatment.

6 Dec 2022

Paper-based synthetic biosensor could help easily detect toxin putrescine in beef

The supply chain that brings meat to market worldwide is highly complex and usually very efficient. But when disruptions in one part of the world can result in transportation delays an ocean and a continent away, meat spoilage becomes a very real risk to food producers, vendors and consumers.

6 Dec 2022

COVID-19 vaccination may cause temporary menstrual disturbances in adolescent girls

The Pfizer-BioNTech mRNA-based COVID-19 vaccine may increase the risk of menstrual disturbances in adolescent girls in their first cycle after vaccination.

6 Dec 2022

MHRA authorizes the use of Pfizer/Biontech COVID-19 vaccine in kids aged 6 months to 4 years

Authorization has today been granted for a new presentation of the Pfizer/BioNTech COVID-19 vaccine (Comirnaty) for use in infants and children aged 6 months to 4 years.

6 Dec 2022

Vaccine hesitancy linked with future COVID-19 vaccination side effects

While the production of COVID vaccines could have been the "light at the end of the pandemic tunnel", this outcome was hampered at critical stages by vaccine hesitancy, defined by the World Health Organization (WHO) as "the reluctance or refusal to vaccinate despite the availability of vaccines".

5 Dec 2022

Vaccine MVA-BN shows consistent, robust immunogenicity and safety results

A phase III clinical trial showed consistent immunogenicity for a freeze-dried formulation of Bavarian Nordic's Modified Vaccinia Ankara.

5 Dec 2022

New insights into how the circadian clock influences T cell responses to vaccination

Research by RCSI University of Medicine and Health Sciences has provided new insights into the mechanism behind how our circadian 24-hour body clock influences our immune response to vaccines, depending on the time of day.

5 Dec 2022

Impact of COVID-19 booster vaccination and breakthrough infection

Researchers assessed the protection elicited after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) booster vaccination or a breakthrough infection against SARS-CoV-2 Omicron variant infection.

5 Dec 2022

Researchers develop a polyvalent lipid nanoparticle mRNA vaccine against Monkeypox virus

Researchers developed an mRNA technology-based vaccine candidate against the monkeypox virus and evaluated its immunogenicity in animal models.

5 Dec 2022

Researchers develop potent yet low-inflammatory mRNA cancer vaccine vectors

Lipid nanoparticle (LNP)-based messenger ribonucleic acid (mRNA) vaccines have recently emerged as a promising strategy for the prevention and treatment of cancers, as well as infectious diseases.

4 Dec 2022

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

Researchers from the United States developed an affordable, non-invasive, inhalable prophylactic treatment consisting of immunoglobulin (Ig) A fused nanobodies against the SARS-CoV-2 Omicron variant.

2 Dec 2022

Vaccination against pertussis in pregnancy and outstanding scientific questions

A recent paper published in Vaccines summarized the data presented and the discussions in the meeting regarding pertussis vaccination in pregnancy (ViP).

2 Dec 2022

The prevalence and risk factors of pediatric post-COVID in a population-based sample

Researchers compared seropositive and seronegative children between the ages of six months and 17 years to assess the risk factors and prevalence of persistent symptoms of post-COVID syndrome.

2 Dec 2022

Antibody responses engendered by maternal SARS-CoV-2 vaccination following initial and booster doses in maternal circulation and breastmilk

Researchers investigated passive immunization of the fetus and neonates by evaluating the antibody responses elicited by primary and booster doses of maternal SARS-CoV-2 vaccination.

2 Dec 2022

The business of clinical trials is booming. Private equity has taken notice.

After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry's more hidden niches: They are pouring billions into the business of clinical drug trials.

2 Dec 2022

Primary and original booster mRNA vaccination can reduce the risk of Omicron-related infection

mRNA COVID-19 vaccines are less effective against Omicron infections than other variants. A study publishing December 1st in the open access journal PLOS Medicine by Margaret L. Lind at the Yale School of Public Health, U.S. and colleagues suggests that the additional protection offered by the initial booster shot may be reduced among people with a previous COVID-19 infection.

1 Dec 2022

First-in-humans test provides promising results for a broadly neutralizing antibody HIV vaccine

A Phase 1 clinical trial provides promising results for a broadly neutralizing antibody (bnAb) HIV vaccine, according to a new study.

1 Dec 2022

Prior infection and vaccination protects against severe outcomes from SARS-CoV-2 Omicron infection

Previous infection with SARS-CoV-2 and booster vaccination protect against ICU admission and mortality following infection with the Omicron variant.

1 Dec 2022

Two experimental mRNA vaccines highly effective in reducing malaria infection and transmission

Malaria is found in more than 90 countries around the world, causing 241 million cases and an estimated 627,000 deaths every year.

1 Dec 2022

Study implicates a specific type of brain cell as key player underlying the impact of stressors

More than 70% of adults will experience at least one traumatic experience, such as a life-threatening illness or accident, violent assault or natural disaster, in their lifetimes and nearly a third will experience four or more, according to global data.

1 Dec 2022

Vaccine News and Research

Latest Vaccine News and Research

Pre-existing SARS-CoV-2 antibodies may increase the breadth of mRNA vaccines, study suggests

Paper-based synthetic biosensor could help easily detect toxin putrescine in beef

COVID-19 vaccination may cause temporary menstrual disturbances in adolescent girls

MHRA authorizes the use of Pfizer/Biontech COVID-19 vaccine in kids aged 6 months to 4 years

Vaccine hesitancy linked with future COVID-19 vaccination side effects

Vaccine MVA-BN shows consistent, robust immunogenicity and safety results

New insights into how the circadian clock influences T cell responses to vaccination

Impact of COVID-19 booster vaccination and breakthrough infection

Researchers develop a polyvalent lipid nanoparticle mRNA vaccine against Monkeypox virus

Researchers develop potent yet low-inflammatory mRNA cancer vaccine vectors

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

Vaccination against pertussis in pregnancy and outstanding scientific questions

The prevalence and risk factors of pediatric post-COVID in a population-based sample

Antibody responses engendered by maternal SARS-CoV-2 vaccination following initial and booster doses in maternal circulation and breastmilk

The business of clinical trials is booming. Private equity has taken notice.

Primary and original booster mRNA vaccination can reduce the risk of Omicron-related infection

First-in-humans test provides promising results for a broadly neutralizing antibody HIV vaccine

Prior infection and vaccination protects against severe outcomes from SARS-CoV-2 Omicron infection

Two experimental mRNA vaccines highly effective in reducing malaria infection and transmission

Study implicates a specific type of brain cell as key player underlying the impact of stressors

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in